Evidence map›Paper›PMID 39659544›Full record

ArticleNanotechnology, science and applications2024

The Substantial Role of Cell and Nanoparticle Surface Properties in the Antibacterial Potential of Spherical Silver Nanoparticles.

Marta Krychowiak-Maśnicka, Weronika Paulina Wojciechowska, Karolina Bogaj, Aleksandra Bielicka-Giełdoń, Ewa Czechowska, Magdalena Ziąbka, Magdalena Narajczyk, Anna Kawiak, Tomasz Mazur, Beata Szafranek and 1 more

Abstract read
In one paragraph

Article in Nanotechnology, science and applications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marta Krychowiak-Maśnicka *University of Gdansk, Intercollegiate Faculty of Biotechnology, Laboratory of Biologically Active Compounds, Gdansk, Poland.ORCID 0000-0002-3617-6572
Weronika Paulina Wojciechowska *University of Gdansk, Intercollegiate Faculty of Biotechnology, Laboratory of Biologically Active Compounds, Gdansk, Poland.
Karolina BogajUniversity of Gdansk, Intercollegiate Faculty of Biotechnology, Laboratory of Biologically Active Compounds, Gdansk, Poland.ORCID 0000-0003-4097-9252
Aleksandra Bielicka-GiełdońUniversity of Gdansk, Faculty of Chemistry, Gdansk, Poland.ORCID 0000-0003-0310-8124
Ewa CzechowskaUniversity of Gdansk, Intercollegiate Faculty of Biotechnology, Laboratory of Experimental and Translational Immunology, Gdansk, Poland.
Magdalena ZiąbkaAGH University of Krakow, Faculty of Materials Science and Ceramics, Department of Ceramics and Refractories, Krakow, Poland.ORCID 0000-0003-0702-7137
Magdalena NarajczykUniversity of Gdansk, Faculty of Biology, Bioimaging Laboratory, Gdansk, Poland.ORCID 0000-0001-9806-8844
Anna KawiakUniversity of Gdansk, Intercollegiate Faculty of Biotechnology, Laboratory of Plant Protection and Biotechnology, Gdansk, Poland.ORCID 0000-0001-8105-2555
Tomasz MazurAGH University of Krakow, Academic Centre for Materials and Nanotechnology, Krakow, Poland.
Beata SzafranekUniversity of Gdansk, Faculty of Chemistry, Gdansk, Poland.
Aleksandra KrólickaUniversity of Gdansk, Intercollegiate Faculty of Biotechnology, Laboratory of Biologically Active Compounds, Gdansk, Poland.ORCID 0000-0001-5231-283X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Although it is well known that the size, shape, and surface chemistry affect the biological potential of silver nanoparticles (AgNPs), the published studies that have considered the influence of AgNP surface on antibacterial activity have not provided conclusive results. This is the first study whose objective was to determine the significance of the surface net charge of AgNPs on their antibacterial potential, attraction to bacterial cells, and cell envelope disruption, considering differences in bacterial surface properties. Methods: We evaluated five commercial AgNP colloids with identical size and shape but different surface ligands. We thoroughly characterized their physicochemical properties, including the zeta potential, hydrodynamic diameter, and polydispersity index, and determined the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC), along with silver absorption into bacterial cells. Moreover, we investigated structural changes in bacteria treated with AgNPs by using a crystal violet assay and electron microscopy. Results: The zeta potential of AgNPs ranged from -47.6 to +68.5 mV, with a hydrodynamic diameter of 29-87 nm and a polydispersity index of 0.349-0.863. Bacterial susceptibility varied significantly (0.5 ≤ MIC ≤ 256 µg Ag/mL; 1 ≤ MBC ≤ 256 µg Ag/mL); we found the lowest susceptibility in bacteria with a cell wall or a polysaccharide capsule. The most active AgNPs (0.5 ≤ MIC ≤ 32 µg Ag/mL; 2 ≤ MBC ≤ 64 µg Ag/mL) had a moderate surface charge (-21.5 and +14.9 mV). The antibacterial potential was unrelated to ion dissolution or cell envelope disruption, and bacterial cells absorbed less of the most active AgNPs (1.75-7.65%). Conclusion: Contrary to previous reports, we found that a moderate surface charge is crucial for the antibacterial activity of AgNPs, and that a significant attraction of the nanoparticle to the cell surface reduces the antibacterial potential of AgNPs. These findings challenge the existing views on AgNP antibacterial mechanisms and interactions with bacterial cells.

Indexed as

cell envelopecell–nanoparticle interactionESKAPEhuman pathogenICP-OESKlebsiella pneumoniae

Identifiers

PMID39659544
PMCPMC11630726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.